Vaksin COVID-19 Moderna

mRNA-1273
Data klinikal
Nama lain	Vaksin COVID-19 Moderna, CX-024414
Data lesen	AS DailyMed: Moderna_COVID-19_Vaccine;
Kaedah; pemberian	Intraotot
Kod ATC	Tidak ada ;
Status perundangan
Status perundangan	AS: Diperintahkan untuk pemakaian darurat (Perintah Pemakaian Darurat);
Pengecam
DrugBank	DB15654;
UNII	EPK39PL4R4;

mRNA-1273, yang lebih dikenali sebagai vaksin COVID-19 Moderna, ialah vaksin COVID-19 yang dibangunoan oleh National Institute of Allergy and Infectious Diseases (NIAID), Biomedical Advanced Research and Development Authority (BARDA), dan Moderna. Vaksin tersebut digunakan melalui suntikan intraotot. Pada 18 Disember 2020, mRNA-1273 dikeluarkan melalui perintah penggunaan darurat oleh Pentadbiran Makanan dan Dadah (FDA) Amerika Syarikat.^[4]^[5]^[6]

Lihat juga

BNT162b2, dari Pfizer/BioNTech

Rujukan

^ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Siaran akhbar). Dicapai pada 18 December 2020.
^ "Moderna COVID-19 Vaccine- cx-024414 injection, suspension". DailyMed. Dicapai pada 20 December 2020.
^ Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). U.S. Food and Drug Administration (FDA) (Laporan). 18 December 2020. Dicapai pada 20 December 2020. Rencana ini mengandungi teks dari sumber yang berada dalam domain awam.
^ "Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine". US National Institutes of Health. 18 December 2020. Dicapai pada 19 December 2020.
^ Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; dll. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152). doi:10.15585/mmwr.mm695152e1.
^ Lovelace Jr, Berkeley (2020-12-19). "FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution". CNBC. Dicapai pada 2020-12-19.

[FDA_PR_20201218-1] "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Siaran akhbar). Dicapai pada 18 December 2020.

[Moderna_COVID-19_Vaccine_FDA_label-2] "Moderna COVID-19 Vaccine- cx-024414 injection, suspension". DailyMed. Dicapai pada 20 December 2020.

[Moderna_COVID-19_Vaccine_FDA_EUA-3] Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). U.S. Food and Drug Administration (FDA) (Laporan). 18 December 2020. Dicapai pada 20 December 2020. Rencana ini mengandungi teks dari sumber yang berada dalam domain awam.

[nih-eua-4] "Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine". US National Institutes of Health. 18 December 2020. Dicapai pada 19 December 2020.

[CDC_ACIP_Moderna_COVID-19_Vaccine-5] Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary; dll. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152). doi:10.15585/mmwr.mm695152e1.

[lovelace-6] Lovelace Jr, Berkeley (2020-12-19). "FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution". CNBC. Dicapai pada 2020-12-19.

[1]

[2]

[3]

[4]

[5]

[6]